Quarterly report pursuant to Section 13 or 15(d)

Segment Reporting (Tables)

v3.20.2
Segment Reporting (Tables)
6 Months Ended
May 31, 2020
Segment Reporting [Abstract]  
Summary of Net Revenue, Cost of Sales, Operating Profit, Depreciation and Amortization, Interest Expense, Income Tax Benefit (Expense), Other Comprehensive Income, and Assets by Segment
The following table shows, by segment: net revenue, cost of sales, depreciation and amortization, operating profit, interest expense, and income tax (expense) benefit for the three and six months ended May 31, 2020 and May 31, 2019:
 
     For the three
months
ended
May 31, 2020
     For the three
months ended
May 31, 2019
 
Net revenue
     
Umbilical cord blood and cord tissue stem cell service
   $ 7,600,902      $ 7,881,697  
PrepaCyte
®
-CB
     57,300        12,040  
Public cord blood banking
     213,642        234,115  
  
 
 
    
 
 
 
Total net revenue
   $ 7,871,844      $ 8,127,852  
  
 
 
    
 
 
 
Cost of sales
     
Umbilical cord blood and cord tissue stem cell service
   $ 1,966,441      $ 2,218,926  
PrepaCyte
®
-CB
     32,014        4,621  
Public cord blood banking
     482,088        404,744  
  
 
 
    
 
 
 
Total cost of sales
   $ 2,480,543      $ 2,628,291  
  
 
 
    
 
 
 
Depreciation and amortization
     
Umbilical cord blood and cord tissue stem cell service
   $ 36,408      $ 46,269  
PrepaCyte
®
-CB
     6,895        9,065  
Public cord blood banking
     —          —    
  
 
 
    
 
 
 
Total depreciation and amortization
   $ 43,303      $ 55,334  
  
 
 
    
 
 
 
Operating income
     
Umbilical cord blood and cord tissue stem cell service
   $ 2,002,877      $ 3,001,600  
PrepaCyte
®
-CB
     17,984        (1,644
Public cord blood banking
     (268,675      (2,503,392
  
 
 
    
 
 
 
Total operating income
   $ 1,752,186      $ 496,564  
  
 
 
    
 
 
 
Interest expense
     
Umbilical cord blood and cord tissue stem cell service
   $ 365,371      $ 424,287  
PrepaCyte
®
-CB
     —          —    
Public cord blood banking
     —          —    
  
 
 
    
 
 
 
Total interest expense
   $ 365,371      $ 424,287  
  
 
 
    
 
 
 
Income tax expense
     
Umbilical cord blood and cord tissue stem cell service
   $ 380,010      $ 50,943  
Prepa
c
Cte
®
-CB
     —          —    
Public cord blood banking
     —          —    
  
 
 
    
 
 
 
Total income tax expense
   $ 380,010      $ 50,943  
  
 
 
    
 
 
 
     For the six
months ended
May 31, 2020
     For the six
months ended
May 31, 2019
 
Net revenue
     
Umbilical cord blood and cord tissue stem cell service
   $ 15,007,190      $ 15,216,724  
PrepaCyte
 
®
-CB
     117,707        37,760  
Public cord blood banking
     367,721        368,480  
  
 
 
    
 
 
 
Total net revenue
   $ 15,492,618      $ 15,622,964  
  
 
 
    
 
 
 
Cost of sales
     
Umbilical cord blood and cord tissue stem cell service
   $ 4,021,515      $ 4,257,530  
PrepaCyte
 
®
-CB
     73,131        164,627  
Public cord blood banking
     889,041        672,361  
  
 
 
    
 
 
 
Total cost of sales
   $ 4,983,687        5,094,518  
  
 
 
    
 
 
 
Depreciation and amortization
     
Umbilical cord blood and cord tissue stem cell service
   $ 73,735      $ 94,186  
PrepaCyte
®
-CB
     13,789        18,128  
Public cord blood banking
     —          —    
  
 
 
    
 
 
 
Total depreciation and amortization
   $ 87,524      $ 112,314  
  
 
 
    
 
 
 
Operating income
     
Umbilical cord blood and cord tissue stem cell service
   $ 3,492,424      $ 4,131,863  
PrepaCyte
®
-CB
     30,379        (144,993
Public cord blood banking
     (521,547      (2,636,644
  
 
 
    
 
 
 
Operating income
   $ 3,001,256      $ 1,350,226  
  
 
 
    
 
 
 
Interest expense
     
Umbilical cord blood and cord tissue stem cell service
   $ 730,670      $ 831,212  
PrepaCyte
®
-CB
     —          —    
Public cord blood banking
     —          —    
  
 
 
    
 
 
 
Total interest expense
   $ 730,670      $ 831,212  
  
 
 
    
 
 
 
Income tax expenses
     
Umbilical cord blood and cord tissue stem cell service
   $ 632,390      $ 155,610  
PrepaCyte
®
-CB
     —          —    
Public cord blood banking
     —          —    
  
 
 
    
 
 
 
Total income taxes
   $ 632,390      $ 155,610  
  
 
 
    
 
 
 
The following table shows the assets by segment as of May 31, 2020 and November 30, 2019:
 
    
As of
May 31, 2020
    
As of
November 30, 2019
 
Assets
     
Umbilical cord blood and cord tissue stem cell service
   $ 31,238,744      $ 28,975,002  
PrepaCyte
®
-CB
     287,448        289,804  
Public cord blood banking
     13,314,420        13,621,354  
  
 
 
    
 
 
 
Total assets
   $ 44,840,612      $ 42,886,160